Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.28 USD | -0.51% | +0.07% | +0.92% |
Apr. 23 | Transcript : HealthStream, Inc., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 22 | Earnings Flash (HSTM) HEALTHSTREAM Posts Q1 Revenue $72.8M, vs. Street Est of $71.9M | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 49.9 and 45.34 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.92% | 829M | C+ | ||
+18.18% | 342B | B- | ||
+30.15% | 225B | B+ | ||
+9.11% | 158B | B | ||
+12.90% | 57.49B | D+ | ||
+17.41% | 33.77B | C+ | ||
+5.56% | 31.23B | B+ | ||
+160.76% | 29.21B | D+ | ||
+32.71% | 21.97B | B- | ||
+46.11% | 14.81B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HSTM Stock
- Ratings HealthStream, Inc.